
· Executive Brief
National Mammography Day 2026
Use the observance to review how people find information, enter the right route, and remain connected through follow-through.

Leadership signal
Recognition becomes useful when leaders inspect the real route.
The strongest use of the observance is operational. Map where questions enter, how requests move, when ownership changes, and how unresolved work becomes visible. The goal is not to make a clinical claim. It is to make the organization’s response easier to understand and manage.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Mammography is a pathway that leaks between the invitation and the answer
Screening mammography looks like a single appointment, but for a health system it is a chain of dependent steps. They include identifying who is due, reaching them, scheduling, imaging, reading, communicating the result, and, for a sizable minority, completing diagnostic follow-up. Each step is owned by a different team, and each can fail without anyone noticing until a woman is lost from the pathway. In a national survey of women aged 50 to 74 in 2022, mammography use within the previous two years ranged from 64.0% to 85.5% across states.[13] It fell from 83.2% among women with no adverse social determinants or health-related social needs to 65.7% among women with three or more.[13]
The pathway also leaks after the screen. A prospective cohort followed 45,186 women with 46,185 abnormal screening mammograms recommended for biopsy across 109 facilities in six states.[14] Of these, 34.6% had not been resolved within 30 days and 12.2% remained unresolved at 90 days.[14] A positive screen that is not resolved is a cost without a benefit, and the women most likely to wait are the women the system already serves least well.
National Mammography Day is a useful moment to look at the whole chain rather than at the campaign. The sections below summarize peer-reviewed evidence on uptake and intervals, outreach and reminder design, mobile units, and diagnostic follow-up timeliness. They also cover breast density notification and supplemental imaging, equity by race, rurality and insurance, the breast imaging workforce, and the communication of results. They are written to sit beside the executive guidance already on this page and to give boards and operating leaders a shared factual base.
The evidence has two consistent messages. First, modest operational changes such as a pre-placed order, a well-designed reminder or a mobile appointment produce measurable gains in completion.[11][9] Second, no single fix closes the gaps that follow race, income, geography and staffing, so leaders need stratified completion data for each step rather than a single screening rate.[14][2]
Current evidence
What the research says about uptake, intervals and detection
Uptake is uneven and has been drifting in the wrong direction. An analysis of national survey data from 2018, 2020 and 2022 found that up-to-date prevalence for breast, cervical and colorectal screening was lower in 2022 than in 2018.[12] Rural residents had 14% to 27% lower odds of being up to date with breast cancer screening than urban residents across the period.[12] The 2022 state-level range of 64.0% to 85.5% among women aged 50 to 74 shows wide variation by geography.[13]
The screening interval itself is being tested as a design choice. The WISDOM trial randomized 28,372 women aged 40 to 74 from all 50 states to annual mammography or to a risk-based schedule, with a median follow-up of 5.1 years.[7] The risk-based schedule was informed by sequencing of nine susceptibility genes, a polygenic risk score and a clinical risk model.[7] The rate of stage IIB or higher cancers was noninferior in the risk-based group (30.0 versus 48.0 per 100,000 person-years; rate difference -18.0, 95% CI -40.2 to 4.1).[7] The risk-based group had substantially fewer mammograms, but biopsy rates were not lower (rate difference 98.7, 95% CI -17.9 to 215.3).[7] Most participants (77%) were non-Hispanic White, which limits generalization.[7]
Reading capacity is also changing. In a nationwide implementation study in Germany, 463,094 women aged 50 to 69 were screened at 12 sites by 119 radiologists between July 2021 and February 2023, 260,739 of them with artificial intelligence support.[10] The cancer detection rate was 6.7 per 1,000 with AI support versus 5.7 per 1,000 without, a 17.6% relative increase (95% CI +5.7% to +30.8%).[10] Recall rates were 37.4 versus 38.3 per 1,000, and the positive predictive value of recall rose from 14.9% to 17.9%.[10] Detection improved without more recalls, which matters when every recall becomes a diagnostic appointment that must be staffed.[10]
Density notification has expanded, and its downstream effects are measurable. A claims-based study of 12,555,082 women aged 40 to 64 screened between 2008 and 2019 found that 9.0% received supplemental ultrasonography and 0.6% received supplemental MRI within six months.[1] State notification mandates were associated with slightly higher odds of ultrasonography (OR 1.09, 95% CI 1.08–1.10), and insurance coverage mandates with much higher odds (OR 1.88, 95% CI 1.86–1.90).[1] Notifications that included information about supplemental screening were associated with an odds ratio of 2.84 (95% CI 2.81–2.86).[1]
Policy, technology and schedule design all shift volumes that a health system must absorb. These include more supplemental ultrasound where coverage exists, different interval mixes where risk-based screening is adopted, and more detected cancers where AI support is deployed.[1][7][10] Each shift lands on the same scheduling, reading and follow-up capacity.
Figure 1
Mammography completion depends on how the invitation is designed and who receives it
Percent of eligible women completing or up to date with screening mammography, as reported in each study. Values are copied from the cited studies [6], [9], [11], [13]; none is estimated.
Data note. Indirect comparison: these values come from different countries, populations, outcome windows and definitions of completion, so the bars show the size of the design and equity effects within each study, not a ranking across studies.
Limitation. Trial values measure completion within a fixed window after an intervention; survey values measure self-reported up-to-date status; none measures diagnostic follow-up.
Figure data (6 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Completed mammogram within 3 months after bulk order plus outreach | 15.4% | Bulk order arm of a pragmatic randomized trial in two primary care regions of one academic health system, 24,632 patients aged 40 to 74, October 2021 to April 2022 | [11] |
| Completed mammography at 6 months with community health worker education and navigation | 39.9% | Intervention arm, 797 low-income Latina women aged 40 or older not up to date, Greater Houston area; comparison arm 20.3% | [6] |
| Screened after usual invitation (control) | 51.1% | Control arm of a cluster randomized trial, women aged 50 to 74 in Normandy, France; 25,099 of 49,067 | [9] |
| Screened after invitation plus mobile unit appointment | 59.8% | Intervention arm of the same trial; 22,964 of 38,382 | [9] |
| Mammogram within 2 years, three or more adverse social determinants or needs | 65.7% | U.S. women aged 50 to 74, national survey, 2022 | [13] |
| Mammogram within 2 years, no adverse social determinants or needs | 83.2% | U.S. women aged 50 to 74, national survey, 2022 | [13] |

Continuum of care
Where the continuum breaks after an abnormal screen
The most consequential break in the mammography continuum is the gap between an abnormal screening result and a completed diagnostic evaluation. In the multistate cohort of women recommended for biopsy, 15,969 of 46,185 abnormal screens (34.6%) were unresolved at 30 days, 7,493 (16.2%) at 60 days and 5,634 (12.2%) at 90 days.[14] These are not rare exceptions; they are a predictable share of every month’s recall volume, and they require a named owner and a visible queue.
Delay is not evenly distributed. Compared with White women, the relative risk of no biopsy within 30 days was 1.66 (95% CI 1.31–2.10) for Asian women and 1.52 (95% CI 1.30–1.78) for Black women.[14] For Hispanic women it was 1.50 (95% CI 1.24–1.81).[14] At 90 days only Black women still had a significantly higher risk (RR 1.28, 95% CI 1.11–1.47).[14] The association persisted after adjustment for individual, neighborhood and health care factors (RR 1.27) and for the screening facility (RR 1.20, 95% CI 1.08–1.34).[14] The authors concluded that measured factors did not fully explain the difference and pointed to systemic and health care system factors as candidates.[14]
The continuum starts earlier than the mammogram. Two pragmatic randomized trials covered 24,632 patients aged 40 to 74 in two primary care regions.[11] Placing a bulk mammogram order before outreach increased completion within three months from 12.7% to 15.4% (absolute difference 2.7%, 95% CI 1.6%-3.6%).[11] A text message after initial outreach increased completion in both trials, by 2.1 and 2.5 percentage points.[11] Endorsement of the message by the patient’s clinician did not add a significant effect (12.5% versus 11.4%).[11] An order that already exists removes a handoff; a message that arrives at the right moment reduces another.
Mobile services can also act as a continuum tool when they are tied to the invitation system. A cluster randomized trial covered 320 areas and 87,449 women aged 50 to 74 in Normandy, France.[9] Women in the intervention arm whose last mammogram was at least 22 months earlier received an appointment at a mobile unit in addition to the usual invitation.[9] Of these, 59.8% were screened compared with 51.1% in the control arm, an 8.7 percentage point increase.[9] The mobile attendees tended to be younger and more socially deprived than women who chose a radiology center.[9]
Taken together, the continuum evidence favors designs that pre-commit the next step. Examples are an order placed before the conversation, an appointment attached to the invitation, and a tracked queue of unresolved abnormal results with race- and facility-stratified timeliness.[11][9][14] Each of these is an operating decision, not a clinical one.
Figure 3
Why the pathway breaks
People
- Breast imaging radiologist and technologist shortages delaying diagnostic slots
- Burnout and part-time shifts reducing reading capacity
- No navigator or community health worker for women not up to date
Process
- Outreach sent without a pre-placed order
- Mobile screens not linked to a fixed-site diagnostic appointment
- No tracked queue for unresolved abnormal results
Technology
- Portal reminders not designed or tested for effect
- Immediate electronic release without a route to a conversation
- AI support not deployed where it could raise detection without recalls
Environment
- Rural distance from radiology centers
- Cost, social isolation and other health-related social needs
- High uninsurance in mobile program populations
Policy
- Density notification without coverage for supplemental imaging
- Letter wording that drives volume the practice cannot absorb
- Screening interval policy that does not match risk
Measurement
- Screening rate tracked without 30-, 60- and 90-day resolution
- Timeliness not stratified by race, ethnicity or facility
- Mobile reach counted without follow-up completion
Unranked qualitative cause-and-effect diagram for the outcome in the box: Eligible women do not complete screening mammography, or an abnormal result is not resolved within 90 days Causes are assembled from the cited literature [1], [2], [3], [5], [6], [8], [9], [10], [11], [12], [13], [14], [15]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Breast imaging radiologist and technologist shortages delaying diagnostic slots; Burnout and part-time shifts reducing reading capacity; No navigator or community health worker for women not up to date |
| Process | Outreach sent without a pre-placed order; Mobile screens not linked to a fixed-site diagnostic appointment; No tracked queue for unresolved abnormal results |
| Technology | Portal reminders not designed or tested for effect; Immediate electronic release without a route to a conversation; AI support not deployed where it could raise detection without recalls |
| Environment | Rural distance from radiology centers; Cost, social isolation and other health-related social needs; High uninsurance in mobile program populations |
| Policy | Density notification without coverage for supplemental imaging; Letter wording that drives volume the practice cannot absorb; Screening interval policy that does not match risk |
| Measurement | Screening rate tracked without 30-, 60- and 90-day resolution; Timeliness not stratified by race, ethnicity or facility; Mobile reach counted without follow-up completion |
Access
Making screening reachable where women already are
Access failures in mammography concentrate among women with the fewest resources. In the 2022 national survey, mammography use among women aged 50 to 74 declined as the number of adverse social determinants of health and health-related social needs increased.[13] It fell from 83.2% with none to 65.7% with three or more.[13] Cost barriers, unreliable transportation, social isolation, reduced work hours, food stamp receipt and life dissatisfaction were all strongly associated with not having a mammogram.[13] The authors concluded that addressing these needs across health care, social services and public health programs might increase mammography use.[13]
Mobile mammography is the most direct access intervention, and the evidence shows whom it reaches. A no-cost mobile program in New York City screened 32,350 women aged 40 to 79 between 2014 and 2019, all of whom had not had a mammogram in the previous 12 months.[15] Of these, 63% reported a household income of $25,000 or less, 30% had no health insurance, 28% identified as African American and 27% as Hispanic.[15] Additional testing was needed for 5,359 women and 68 breast cancers were detected.[15] The program demonstrates reach, and it also demonstrates the follow-up load that reach creates: every mobile screen that is abnormal needs a fixed-site diagnostic pathway to return to.[15]
The randomized evidence from Normandy adds causal weight. Attaching a mobile unit appointment to the standard invitation raised participation from 51.1% to 59.8%, in areas more than 15 minutes from a radiology center, which is exactly where geographic inequity sits.[9] For a U.S. health system, the design lesson is that a mobile unit works best as a scheduled extension of the invitation system rather than as a stand-alone event.[9]
Digital access is a second front. A scoping review of 32 U.S. studies published between 2014 and 2024 found that 18 of 21 studies comparing portal users with nonusers reported an association with higher screening.[5] Provider recommendation for self-scheduling was a significant moderator, and patient activation, cancer worry and choice architecture were among significant mechanisms.[5] The authors cautioned that most studies attributed the mechanism to prior literature rather than direct observation, so portals should be treated as a promising channel rather than a proven one.[5]
Reminder design within that channel matters. A randomized quality improvement study tested redesigned electronic reminders built on a behaviorally informed framework at outpatient clinics of one academic health system.[4] They produced mammography scheduling or completion in 25 of 212 patients (11.8%) compared with 13 of 212 (6.1%) for existing reminders.[4] The same redesign made no difference for retinal or hemoglobin A1c testing, and a further personalized version did not outperform the redesigned message.[4] Access, in other words, includes the wording and timing of the message that opens the door.[4]
Executive guidance · System route
Map the path from first contact to verified follow-through.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Listen
Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entry
Publish a plain-language first step and identify who receives requests through each approved channel.
Coordinate the partner route
Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal.
Protect transitions
Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learn
Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Listen | Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions. |
| Clarify entry | Publish a plain-language first step and identify who receives requests through each approved channel. |
| Coordinate the partner route | Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal. |
| Protect transitions | Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations. |
| Verify and learn | Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals. |
Equity and trust
Equity gaps follow race, geography and income through every step
Equity in mammography is a question about each step of the pathway, not only about who is screened. Rural residents had 14% to 27% lower odds of being up to date with breast cancer screening than urban residents across 2018 to 2022.[12] Unlike colorectal and cervical screening, the rural gap in breast screening did not close by 2022.[12] Among women aged 50 to 74 in 2022, mammography use fell from 83.2% among women with no adverse social determinants or health-related social needs to 65.7% among women with three or more.[13]
After an abnormal result, racial and ethnic differences in timeliness are large early and persistent for Black women. The relative risk of no biopsy within 30 days was 1.66 for Asian women, 1.52 for Black women and 1.50 for Hispanic women compared with White women.[14] Black women still had a relative risk of 1.20 (95% CI 1.08–1.34) at 90 days after adjustment for individual, neighborhood, health care and facility factors.[14] The authors’ interpretation that unmeasured systemic factors contribute is a direct challenge to health systems to examine their own scheduling, communication and facility practices by race.[14]
Community-based navigation has randomized evidence in populations that systems often fail to reach. A trial in the Greater Houston area enrolled 797 low-income Latina women aged 40 or older who were not up to date on mammography.[6] It tested community health worker-delivered group education with optional telephone coaching and navigation against a delayed-intervention comparison.[6] At six months, mammography completion was 39.9% in the intervention arm and 20.3% in the comparison arm, a statistically significant difference.[6]
Mobile programs reach populations with high uninsurance and low income, as the New York City data on 30% uninsured and 63% with incomes of $25,000 or less show.[15] Normandy mobile attendees tended to be more deprived than women attending radiology centers.[9] Equity gains from mobile units, however, depend on what happens to the 5,359 women in a program like New York’s who need additional testing.[15] A mobile screen that produces an unresolved abnormal result reproduces the delay pattern described above.[14]
Trust is built when the organization can show that the women most likely to be delayed are being tracked. In the staffing survey, 75.7% of understaffed breast imaging physicians reported delayed diagnostic imaging, which suggests delay can be a capacity problem rather than a patient behavior problem.[2][14] Executives should resist explanations that locate the gap in the patient alone.

Human infrastructure
The people and capacity behind every mammogram and callback
The breast imaging workforce is the constraint that converts awareness into completed screens and timely diagnostic evaluations. In a 26-question survey of breast imaging physicians conducted from May 31 to June 28, 2024, 226 respondents reported feeling understaffed.[2] Of these, 75.7% (171 of 226) reported patient delays in diagnostic imaging and 68.6% (155 of 226) reported delays in procedures.[2] The staffing shortage, in other words, shows up first in the callback queue.
The same survey describes the human cost. Among understaffed respondents, 87.6% reported increased stress, 76.6% reported longer working hours and 76.6% reported burnout, while 56.2% had seen colleagues move to part-time work and 35.8% had seen colleagues switch practice types.[2] Moonlighting was the most common short-term response (44.2%), and for longer-term solutions 53.1% reported offering part-time employment to recruit radiologists and 38.1% to retain them.[2] About one-third (34.1%) used advanced practice providers, often for procedural support and patient navigation.[2]
Artificial intelligence support is one of the few workforce levers with large-scale real-world evidence. In the German implementation study of 463,094 screened women, AI-supported reading was associated with a 17.6% higher cancer detection rate.[10] Recall rates were essentially unchanged (37.4 versus 38.3 per 1,000), and the positive predictive value of biopsy rose from 59.2% to 64.5%.[10] For leaders, the operational meaning is that AI support can raise detection without adding to the diagnostic workload that understaffed practices already struggle to carry.[10][2]
Navigation is also workforce. In the Houston trial, community health worker education and optional telephone navigation nearly doubled six-month mammography completion among low-income Latina women (39.9% versus 20.3%).[6] In the two primary care outreach trials, the gains came from a bulk order and an automated text message rather than from additional clinician time, and clinician endorsement of the message added nothing significant.[11] The implication is that the workforce plan for mammography should distinguish tasks that need a radiologist, tasks that need a navigator and tasks that can be automated.[11][6]
The workforce also sets the ceiling on what policy can achieve. When supplemental ultrasonography use rises with coverage mandates, the added examinations are read and scheduled by the same understaffed practices.[1][2] Executives reviewing capacity for National Mammography Day can ask one question of each role: if recall volume rose by a fifth next quarter, who would absorb it and which patients would wait?[2][14]
Executive guidance · Operating dashboard
Measure whether the operating route works as intended.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Entry-point clarity
Can people and staff identify the approved first step without searching across conflicting instructions?
- Candidate local measure
- Locally defined contact, routing, and repeat-contact signals by channel and service.
Executive guidance · Signal
Ownership reliability
Does a specific team accept each request and make its status visible?
- Candidate local measure
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
Executive guidance · Signal
Partner-route reliability
Do participating teams share one current route and understand who owns each dependency?
- Candidate local measure
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Executive guidance · Signal
Improvement closure
Does the organization correct recurring friction and report what changed?
- Candidate local measure
- Selected barriers, assigned actions, completion status, and post-change review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Entry-point clarity | Executive sponsor and operational lead |
| Ownership reliability | Operational owner and participating teams |
| Partner-route reliability | Sending and receiving owners |
| Improvement closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Keep work owned when it crosses a boundary.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Name the sending and receiving owners, shared information, current status, and unresolved dependency.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Ask questions that connect intent, ownership, and results.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Entry-point clarity | Can people and staff identify the approved first step without searching across conflicting instructions? | Executive sponsor and operational lead | At campaign launch and close |
| Ownership reliability | Does a specific team accept each request and make its status visible? | Operational owner and participating teams | At a locally defined cadence |
| Partner-route reliability | Do participating teams share one current route and understand who owns each dependency? | Sending and receiving owners | At a locally defined cadence |
| Improvement closure | Does the organization correct recurring friction and report what changed? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable mammography pathway
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Pre-placed mammogram order before outreach | Eligible women receive a message with no next step and completion stays near one in eight | Primary care medical director with population health lead | Share of outreach cohort with an active order and completion within 3 months |
| Tested reminder and text message wording | Messages that feel right but do not move completion | Patient experience lead with digital health team | Completion by message version, reviewed each cycle |
| Mobile unit appointments attached to the invitation | Mobile events reach few of the women furthest from imaging sites | Mobile program director with scheduling lead | Participation among invited women by distance and deprivation |
| Mobile and fixed-site abnormal results routed to one diagnostic queue | Women screened in the community are lost before diagnostic evaluation | Breast imaging section chief | Share of mobile abnormal results with diagnostic evaluation within 30 days |
| Abnormal result resolution tracked at 30, 60 and 90 days by race, ethnicity and facility | Black women and other groups wait longer without anyone seeing it | Chief quality officer with breast imaging lead | Stratified resolution rates reviewed monthly |
| Density notification paired with a route to a clinician conversation | Anxiety and confusion rise, primary care absorbs unplanned demand | Chief medical officer with primary care and radiology leads | Volume of density-related contacts and supplemental imaging requests by site |
| Breast imaging staffing matched to recall and supplemental imaging volume | Diagnostic and procedure delays driven by capacity, with staff burnout | Chief operating officer with radiology chair | Diagnostic slot wait time and reads per radiologist by month |
Control points derived from the cited evidence [1], [2], [6], [8], [9], [11], [14], [15] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Communicating results and risk without creating confusion
Communication in mammography now happens largely through electronic release. A 2026 review of patient preferences across the breast imaging continuum notes that federal requirements for immediate electronic release of most records have changed how results are reported.[3] The review adds that this improves transparency and access but may conflict with established preferences for how screening, diagnostic, biopsy and risk assessment results are delivered.[3] Earlier studies, most predating widespread portal use, found that patients prioritize timely communication while their preferred method depends on how serious or emotionally significant the result is.[3]
Density notification is the clearest test of what written communication can and cannot do. A multisite randomized trial within a population screening program in Queensland, Australia, enrolled 3,107 women aged 40 or older with dense breasts, with 2,401 analyzed at eight weeks.[8] Women were randomized to standard care without notification, literacy-sensitive written information, or a link to an online video.[8] Notified women were more likely to report feeling anxious (OR 1.30 and 1.28) and confused (OR 1.92 and 1.76), and no more likely to feel informed (OR 0.83 and 0.80).[8] They were more likely to intend to talk to a general practitioner about their results (RR 2.08 and 1.71) and to rely on that practitioner for advice about supplemental screening (RR 2.61 and 2.29).[8]
The authors concluded that notification may have adverse outcomes, including additional consultation burden for general practitioners.[8] For U.S. systems that notify, the finding argues for pairing the required letter with a clear route to a conversation.[3] The trial shows that women receiving notification turn to their primary care clinician rather than acting on the letter alone.[8] The claims-based evidence that notification letters including supplemental screening information were associated with an odds ratio of 2.84 for ultrasonography suggests that wording matters at scale.[1] That makes wording a governance decision.
Outreach messages also need evidence rather than intuition. Text messaging after initial outreach raised mammogram completion in both pragmatic trials, while a clinician-endorsed version of the message did not outperform standard wording.[11] A behaviorally redesigned portal reminder raised mammography scheduling or completion from 6.1% to 11.8% in one cycle, but a personalized version added nothing further, and the same approach did not move diabetes-related testing.[4] The scoping review of portals likewise found provider recommendation for self-scheduling and choice architecture in secure messaging among significant factors, though few studies tested such factors directly.[5]
Public communication during National Mammography Day should therefore do three things the evidence supports. It should describe a concrete next step rather than general encouragement, and make the route to a person clear for anyone who receives a density notice or an abnormal result.[11][8] It should also avoid promising a timeline that the diagnostic workforce cannot keep.[2] Trust grows when the message, the appointment and the callback all come from the same operating system.

Executive guidance · 90-day plan
Move from listening to a verified improvement in 90 days.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how National Mammography Day communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how National Mammography Day communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Carry one accountable improvement beyond the campaign window.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Listen to the people closest to the route, assign one barrier, and verify the change.
Executive action kit · Day observance
Turn National Mammography Day into accountable action.
Use the observance to review how people find information, enter the right route, and remain connected through follow-through.
Leadership focus
Use this observance to examine trustworthy information, prevention access, and community connection. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, access, coordination, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review language, disability, transportation, digital access, geography, trust, and other barriers using protected feedback and locally appropriate data.
Five-minute briefing
Inspect the operating sequence
Listen with people using the pathway, frontline teams, operational leaders, and community partners. Find one a message, request, referral, or handoff that does not reach an accountable owner, then test the locally approved route from entry through acknowledged follow-through.
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined contact, routing, and repeat-contact signals by channel and service.
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Public Health and Community Partners
Staff communication template
During National Mammography Day, our organization will connect awareness with a practical review of the information, access, coordination, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
National Mammography Day is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Kang DW, Chetlen A, Zhou S, Wang L, Leslie D, Shen C. Dense Breast Legislation and Supplemental Breast Imaging Among Women Undergoing Mammography. JAMA Network Open. 2026;9(7):e2626008. https://doi.org/10.1001/jamanetworkopen.2026.26008
- 2.Coffey K, Grimm LJ, Bhole S, Parikh JR, Dontchos BN, et al. Breast Imaging Staffing Shortages: Perceived Clinical Impact and Potential Solutions. Journal of Breast Imaging. 2026:wbag041, online ahead of print, July 27, 2026. https://doi.org/10.1093/jbi/wbag041
- 3.Maimone S, Dodelzon K, Kendell AE, Coffey K, Porembka JH. Patient Preferences for Result Communication Across the Breast Imaging Continuum: A Review. Journal of Breast Imaging. 2026:wbag037, online ahead of print, July 24, 2026. https://doi.org/10.1093/jbi/wbag037
- 4.Krelle H, King WC, Tsuruo S, Klapheke N, Lu J, et al. Bridging the Gap: Portal Messages as a Tool to Improve Breast Cancer and Diabetes Screening Rates. Journal of General Internal Medicine. 2026;41(9):2624-2628. https://doi.org/10.1007/s11606-026-10452-0
- 5.Gold RS, Henrikson NB, Issaka RB, Gillespie EF, Schuttner L, Weiner BJ, Marcotte LM. How and Under What Conditions Do Patient Portals Improve Cancer Screening Completion: A Scoping Review. AJPM Focus. 2026;5(3):100481. https://doi.org/10.1016/j.focus.2026.100481
- 6.Savas LS, Heredia NI, Huyan Y, Coan S, Martin S, et al. A randomized controlled trial to evaluate an adapted community health worker-delivered breast and cervical cancer screening education and navigation intervention for underserved Latina adults. Frontiers in Oncology. 2026;16:1687113. https://doi.org/10.3389/fonc.2026.1687113
- 7.Esserman LJ, Fiscalini AS, Naeim A, van’t Veer LJ, Kaster A, Scheuner MT, et al. Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial. JAMA. 2026;335(9):763-774. https://doi.org/10.1001/jama.2025.24784
- 8.Nickel B, Ormiston-Smith N, Cvejic E, Isautier J, Hammerton L, et al. Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen. BMJ. 2025;391:e083649. https://doi.org/10.1136/bmj-2024-083649
- 9.Koné G, Beuriot S, Launay L, Launoy G, Guillaume E. Effect of a mobile mammography unit on participation and equity in breast cancer screening: a cluster randomised trial in Normandy, France. The Breast. 2025;86:104686 (online December 2025; April 2026 issue). https://doi.org/10.1016/j.breast.2025.104686
- 10.Eisemann N, Bunk S, Mukama T, Baltus H, Elsner SA, Gomille T, et al. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening. Nature Medicine. 2025;31(3):917-924. https://doi.org/10.1038/s41591-024-03408-6
- 11.Mehta SJ, Rhodes C, Linn KA, Reitz C, McDonald C, et al. Behavioral Interventions to Improve Breast Cancer Screening Outreach: Two Randomized Clinical Trials. JAMA Internal Medicine. 2024;184(7):761-768. https://doi.org/10.1001/jamainternmed.2024.0495
- 12.Benavidez GA, Sedani AE, Felder TM, Asare M, Rogers CR. Rural-urban disparities and trends in cancer screening: an analysis of Behavioral Risk Factor Surveillance System data (2018-2022). JNCI Cancer Spectrum. 2024;8(6):pkae113. https://doi.org/10.1093/jncics/pkae113
- 13.Miller JW, King JA, Trivers KF, Town M, Sabatino SA, Puckett M, Richardson LC. Vital Signs: Mammography Use and Association with Social Determinants of Health and Health-Related Social Needs Among Women – United States, 2022. MMWR Morbidity and Mortality Weekly Report. 2024;73(15):351-357. https://doi.org/10.15585/mmwr.mm7315e1
- 14.Lawson MB, Bissell MCS, Miglioretti DL, Eavey J, Chapman CH, Mandelblatt JS, et al. Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity. JAMA Oncology. 2022;8(8):1115-1126. https://doi.org/10.1001/jamaoncol.2022.1990
- 15.Botty van den Bruele A, Sevilimedu V, Jochelson M, Formenti S, Norton L, Sacchini V. Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program. npj Breast Cancer. 2022;8(1):14. https://doi.org/10.1038/s41523-022-00381-6
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| National mammography use and association with social needs | [13] | 2024 | Executive opening | Self-reported 2022 national survey; prevalence of a mammogram within two years, not completion of follow-up. |
| Rural-urban disparities and declining up-to-date prevalence | [12] | 2024 | Current evidence | Self-reported survey data for 2018, 2020 and 2022; county-level rurality classification. |
| Risk-based versus annual screening intervals | [7] | 2026 | Current evidence | Pragmatic online trial; 77% non-Hispanic White; median follow-up 5.1 years. |
| AI-supported reading: detection, recall and positive predictive value | [10] | 2025 | Current evidence | Nonrandomized nationwide implementation within an organized screening program in Germany, women 50 to 69; context differs from U.S. practice. |
| Density legislation and supplemental imaging use | [1] | 2026 | Current evidence | Administrative claims for women aged 40 to 64, 2008 to 2019; no clinical density data; association, not causation. |
| Timeliness of biopsy after abnormal screening by race and ethnicity | [14] | 2022 | Continuum of care | Multistate prospective cohort 2009 to 2019; residual confounding and facility mix; biopsy recommendation only. |
| Bulk ordering and text messaging for outreach | [11] | 2024 | Continuum of care | Two primary care regions of one health system; three-month completion; modest absolute effects. |
| Mobile mammography unit effect on participation | [9] | 2025 | Continuum of care | Organized screening program in France for women 50 to 74; cluster design; context differs from U.S. systems. |
| Reach of a no-cost urban mobile program | [15] | 2022 | Access | Single-program descriptive data 2014 to 2019; no comparison group; follow-up completion not reported in abstract. |
| Patient portals and screening completion | [5] | 2026 | Access | Scoping review of 32 heterogeneous U.S. studies; mechanisms mostly inferred rather than observed. |
| Behaviorally redesigned portal reminders | [4] | 2026 | Access | Small randomized quality improvement cycles in one academic system; scheduling or completion outcome. |
| Community health worker education and navigation | [6] | 2026 | Equity and trust | Single metropolitan area; low-income Latina women; six-month completion from follow-up surveys. |
| Breast imaging staffing shortages and their perceived impact | [2] | 2026 | Human infrastructure | Self-selected survey of society members; perceptions of delay, not measured wait times. |
| Patient preferences for result communication | [3] | 2026 | Public communication | Narrative review; much underlying literature predates immediate electronic release. |
| Psychological and service effects of density notification | [8] | 2025 | Public communication | Australian population program; eight-week outcomes are intentions and feelings, not supplemental imaging use. |

About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.

